Efficacy of fluticasone propionate aerosol versus budesonide suspension in treatment of recurrent wheezing caused by bronchiolitis

LAN Wei-Ping, WANG Jing, DAI Chuan-Lin, PAN Jia-Hua

Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (4) : 316-319.

PDF(450 KB)
PDF(450 KB)
Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (4) : 316-319. DOI: 10.7499/j.issn.1008-8830.2016.04.007
CLINICAL RESEARCH

Efficacy of fluticasone propionate aerosol versus budesonide suspension in treatment of recurrent wheezing caused by bronchiolitis

  • LAN Wei-Ping, WANG Jing, DAI Chuan-Lin, PAN Jia-Hua
Author information +
History +

Abstract

Objective To investigate the efficacy of fluticasone propionate aerosol (flixotide) versus budesonide suspension in the treatment of recurrent wheezing caused by bronchiolitis. Methods A total of 214 infants with newly diagnosed bronchiolitis were randomly divided into flixotide treatment (106 infants) and budesonide treatment groups (108 infants), and were given aerosol inhalation of flixotide or budesonide for 3 months after achieving remission of clinical symptoms. Another 136 infants with bronchiolitis who did not receive regular inhalation of corticosteroid after achieving remission of clinical symptoms were enrolled as the control group. The follow-up visits were performed for 1 year, and the effects of the two therapeutic methods on recurrent wheezing were evaluated. Results Compared with the control group, both the flixotide and budesonide treatment groups had significantly fewer times of wheezing episodes within 1 year and a significantly lower recurrence rate of wheezing within the first 3 months after regular inhalation of corticosteroid, but no significant differences were observed between the two treatment groups. The amount of corticosteroid inhaled and hospital costs in the budesonide treatment group were significantly higher than in the flixotide treatment group (P<0.01). Conclusions Continuous inhalation of flixotide or budesonide after remission of clinical symptoms in children with bronchiolitis can reduce wheezing episodes and the recurrence of wheezing, and flixotide treatment is superior to budesonide treatment in the aspects of hospital costs and the amount of corticosteroid used.

Key words

Bronchiolitis / Inhaled corticosteroid / Recurrent wheezing / Child

Cite this article

Download Citations
LAN Wei-Ping, WANG Jing, DAI Chuan-Lin, PAN Jia-Hua. Efficacy of fluticasone propionate aerosol versus budesonide suspension in treatment of recurrent wheezing caused by bronchiolitis[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(4): 316-319 https://doi.org/10.7499/j.issn.1008-8830.2016.04.007

References

[1] Florin TA, Byczkowski T, Ruddy RM, et al. Variation in the management of infants hospitalized for bronchiolitis persists after the 2006 American Academy of Pediatrics bronchiolitis guidelines[J]. J Pediatr, 2014, 165(4): 786-792.
[2] Rolfsjord LB, Skjerven HO, Bakkeheim E, et al. Children hospitalised with bronchiolitis in the first year of life have a lower quality of life nine months later[J]. Acta Paediatr, 2015, 104(1): 53-58.
[3] Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia[J]. Acta Paeditr, 2014, 103(10): 1094-1099.
[4] 余阗, 李云, 陈敏. 毛细支气管炎患儿肺功能特点及应用吸入性糖皮质激素的疗效[J]. 实用儿科临床杂志, 2007, 22(22): 1703-1704.
[5] 江载芳, 申昆玲. 病毒性肺炎[M]//胡亚美, 江载芳. 诸福棠实用儿科学上册. 第7 版. 北京: 人民卫生出版社, 2002: 1199-1201.
[6] Wang EE, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections[J]. Am Rev Respir Dis, 1992, 145(1): 106-109.
[7] Global initiative for asthma. Global strategy for asthma management and prevention (2014 revision)[EB/OL].[2015-11-23]. http://www.ginasthma.com.
[8] Teeratakulpisarn J, Pientong C, Ekalaksananan T, et al. Rhinovirus infection in children hospitalized with acute bronchiolitis and its impact on subsequent wheezing or asthma: a comparison of etiologies[J]. Asian Pac J Allergy Immunol, 2014, 32(3): 226-234.
[9] Proud D. Role of rhinovirus infections in asthma[J]. Asian Pac J Allergy Immunol, 2011, 29(3): 201-208.
[10] Tantilipikorn P, Auewarakul P. Airway allergy and viral infection[J]. Asian Pac J Allergy Immunol, 2011, 29(2): 113-119.
[11] Turunen R, Koistinen A, Vuorinen T, et al. The first wheezing episode: respiratory virus etiology, atopic characteristics and illness severity.Pediatr Allergy Immunol, 2014, 25(8): 796-803.
[12] Piippo-Savolainen E, Korppi M. Wheezy babies-wheezy adults? review on long-term outcome until adulthood after early childhood wheezing[J]. ActaPaediatr, 2008, 97(1): 5-11.
[13] Backman K, Piippo-Savolainen E, Ollikainen H, et al. Irreversible airway obstruction in adulthood after bronchiolitis in infancy: Evidence from a 30-year follow-up study[J]. Respir Med, 2014, 108(1): 218-223.
[14] 刘洁明, 周也荻, 刘晓艳, 等. 雾化吸入糖皮质激素联合特布他林及异丙托溴铵治疗毛细支气管炎的疗效及预后[J]. 实用儿科临床杂志, 2008, 23(22): 1778-1779.

PDF(450 KB)

Accesses

Citation

Detail

Sections
Recommended

/